Search hospitals > Washington > Kennewick
Kadlec Clinic Hematology and Oncology
Claim this profileKennewick, Washington 99336
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
327 reported clinical trials
9 medical researchers
Summary
Kadlec Clinic Hematology and Oncology is a medical facility located in Kennewick, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Kadlec Clinic Hematology and Oncology is involved with conducting 327 clinical trials across 464 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
99 reported clinical trials
175 drugs studied
Charles W. DrescherProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Tumors
44 reported clinical trials
85 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Recurrence
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
26 reported clinical trials
63 drugs studied
Clinical Trials running at Kadlec Clinic Hematology and Oncology
Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Pancreatic Cancer
Gastric Cancer
Multiple Myeloma
Adenocarcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Inavolisib + Fulvestrant vs Alpelisib + Fulvestrant
for Breast Cancer
This is a Phase III, multicenter, randomized, open-label, global study designed to evaluate the efficacy and safety of inavolisib plus fulvestrant compared with alpelisib plus fulvestrant in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) -negative, PIK3CA-mutated, locally advanced (LA) or metastatic breast cancer (mBC), who progressed during or after cyclin dependent kinase 4/6i (CDK4/6i)-based therapy.
Recruiting2 awards Phase 310 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kadlec Clinic Hematology and Oncology?
Kadlec Clinic Hematology and Oncology is a medical facility located in Kennewick, Washington. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Leukemia and other specialties. Kadlec Clinic Hematology and Oncology is involved with conducting 327 clinical trials across 464 conditions. There are 9 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Where is Kadlec Clinic Hematology and Oncology located?
The Kadlec Clinic Hematology and Oncology is located at 7360 W Deschutes Ave, Kennewick, WA 99336.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Kadlec Clinic Hematology and Oncology, patients or guarantors can obtain a free Financial Assistance Application directly from Kadlec, by mail, or by downloading it from www.kadlec.org. Completed applications, along with required documentation, should be submitted as instructed. Additionally, patients can manage their medical bills, including viewing and secure online payment, through the Kadlec Regional Medical Center website.
What insurance does Kadlec Clinic Hematology and Oncology accept?
Kadlec Clinic Hematology and Oncology accepts a variety of insurance plans, including but not limited to Aetna Choice POS II, Aetna Managed Choice POS Open Access, and Aetna Signature Administrators PPO. The clinic specializes in diagnosing and treating blood diseases and cancer, offering services such as advanced diagnostic imaging, chemotherapy, and genetic counseling, alongside support services like oncology dietitian/nutrition counseling and survivorship programs. It has been awarded a three-year accreditation with commendation by the American College of Surgeons Commission on Cancer, highlighting its commitment to providing care that meets the highest standards.
What awards or recognition has Kadlec Clinic Hematology and Oncology received?
Kadlec Clinic Hematology and Oncology, located in Kennewick, Washington, is renowned for its exceptional cancer care, boasting five national cancer accreditations. It has also been awarded a three-year accreditation with commendation by the American College of Surgeons Commission on Cancer, affirming its commitment to providing care that adheres to the highest standards.